VFA
RLAY icon

Valeo Financial Advisors’s Relay Therapeutics RLAY Stock Holding History

Valeo Financial Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$668K Sell
35,687
-27
-0.1% -$392 0.01% 382
2026
Q1 		$355K Buy
+35,714
New +$320K 0.01% 493
2021
Q2 		– Sell
-202
Closed -$7K – 1533
2021
Q1 		$7K Sell
202
-7
-3% -$304 ﹤0.01% 1469
2020
Q4 		$9K Hold
209
– – ﹤0.01% 1226
2020
Q3 		$9K Buy
+209
New +$7.97K ﹤0.01% 1113

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Valeo Financial Advisors's RLAY Position: Q2 2026 in Review

Valeo Financial Advisors reduced its Relay Therapeutics (RLAY) stake by 0.08% in Q2 2026, selling an estimated $392 and leaving 35,687 shares worth $668K. The position accounts for 0.01% of the portfolio, ranked #382.

Valeo Financial Advisors first reported a position in RLAY in Q3 2020 and has held it in 5 quarters since. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Valeo Financial Advisors held 35,687 shares of Relay Therapeutics worth $668K as of Q2 2026.
  • Valeo Financial Advisors sold 27 Relay Therapeutics shares in Q2 2026, an estimated $392.
  • Relay Therapeutics made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #382 holding.
  • Valeo Financial Advisors first reported a position in Relay Therapeutics in Q3 2020 and has held it in 5 quarters since.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.